Identification of IL-17F/frequent exacerbator endotype in asthma
…, A Folino, F Gallo, GM Massaglia, G Favatà… - Journal of Allergy and …, 2017 - Elsevier
… (Fig 3, G) cells. For the other significant correlations among bronchial/nasal IL-17–related
cytokines and inflammatory cells see the Online Repository and Figs E6 and E7 at www.…
cytokines and inflammatory cells see the Online Repository and Figs E6 and E7 at www.…
Nasal IL‐17F is related to bronchial IL‐17F/neutrophilia and exacerbations in stable atopic severe asthma
…, G Ciprandi, A Di Stefano, GM Massaglia, G Favatà… - Allergy, 2015 - Wiley Online Library
Severe asthma ( SA ) is associated with neutrophil recruitment and T helper (T H )17
chemokine overexpression in bronchial biopsies. We aimed to evaluate IL ‐17A and IL ‐17F …
chemokine overexpression in bronchial biopsies. We aimed to evaluate IL ‐17A and IL ‐17F …
Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma
…, V Sorbello, D Vallese, GM Massaglia, G Favatà… - 2016 - Eur Respiratory Soc
Severe asthma might be associated with neutrophil recruitment and Th17 chemokines over-expression
in bronchial biopsies. We studied IL-17-related cytokines in nasal/bronchial …
in bronchial biopsies. We studied IL-17-related cytokines in nasal/bronchial …
[PDF][PDF] 214. Trials in asthma: asthma exacerbations and severe asthma
…, A Di Stefano, GM Massaglia, B Andreetto, G Favatà - ers-education.org
… Results: Genotyping of rs20541 showed that 26 A/A, 77 A/G and 79 G/G. D min (U) of the
3 genotypes was 1.17±0.300 in A/A, 1.99±0.35 in A/G and 2.85±0.39 in G/G. D min in the 3 …
3 genotypes was 1.17±0.300 in A/A, 1.99±0.35 in A/G and 2.85±0.39 in G/G. D min in the 3 …
Over-expression of Th17-related cytokines in bronchial and nasal submucosa in severe asthma
…, B Andreetto, G Favatà, S Conticello, G Ciprandi - 2012 - Eur Respiratory Soc
In severe asthma neutrophil recruitment in bronchial submucosa is associated with steroid
resistance, and in addition Th17-derived cytokines are important in induction and activation of …
resistance, and in addition Th17-derived cytokines are important in induction and activation of …
[HTML][HTML] Mechanisms of corticosteroid resistance in type 17 asthma
L Hong, T Herjan, K Bulek, J Xiao… - The Journal of …, 2022 - journals.aai.org
IL-17A plays an important role in the pathogenesis of asthma, particularly the neutrophilic
corticosteroid (CS)-resistant subtype of asthma. Clinical studies suggest that a subset of …
corticosteroid (CS)-resistant subtype of asthma. Clinical studies suggest that a subset of …
Asthma from immune pathogenesis to precision medicine
Asthma is characterized by multiple immunological mechanisms (endotypes) determining
variable clinical presentations (phenotypes). The identification of endotypic mechanisms is …
variable clinical presentations (phenotypes). The identification of endotypic mechanisms is …
Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease
G Pollara, CT Turner, J Rosenheim… - Science translational …, 2021 - science.org
Host immune responses at the site of Mycobacterium tuberculosis infection can mediate
pathogenesis of tuberculosis (TB) and onward transmission of infection. We hypothesized that …
pathogenesis of tuberculosis (TB) and onward transmission of infection. We hypothesized that …
[HTML][HTML] Tryptophan metabolic pathway and neopterin in asthmatic children in clinical practice
A Licari, D Fuchs, G Marseglia, G Ciprandi - Italian Journal of Pediatrics, 2019 - Springer
Tryptophan metabolic pathway is involved in pathogenic mechanisms of asthma. This study
aimed to evaluate tryptophan metabolites and neopterin in a group of asthmatic children. …
aimed to evaluate tryptophan metabolites and neopterin in a group of asthmatic children. …
Mapping atopic dermatitis and anti–IL-22 response signatures to type 2–low severe neutrophilic asthma
…, P Montuschi, G Roberts… - Journal of allergy and …, 2022 - Elsevier
Background Transcriptomic changes in patients who respond clinically to biological therapies
may identify responses in other tissues or diseases. Objective We sought to determine …
may identify responses in other tissues or diseases. Objective We sought to determine …